XTL Biopharmaceuticals Ltd. (FRA:H2K2)
0.6750
+0.0300 (4.65%)
At close: Dec 4, 2025
-61.43% (1Y)
| Market Cap | 6.99M |
| Revenue (ttm) | 435.62K |
| Net Income (ttm) | -991.98K |
| Shares Out | n/a |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 7 |
| Open | 0.6750 |
| Previous Close | 0.6450 |
| Day's Range | 0.6750 - 0.6750 |
| 52-Week Range | 0.6200 - 4.0000 |
| Beta | n/a |
| RSI | 40.19 |
| Earnings Date | Nov 18, 2025 |